Lenalidomide
Last Updated: 09/19/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7158 publications
Predictive value of next-generation sequencing-based measurable residual disease quantitative stratification for early disease progression in newly diagnosed multiple myeloma after induction therapy
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: September 07, 2026
MRD-guided induction-intensification with daratumumab-carfilzomib-based regimen followed by ASCT in patients with newly diagnosed multiple myeloma.
Journal: Leukemia & lymphoma
Published: September 06, 2026
Paraneoplastic pemphigus associated with follicular lymphoma and myasthenia gravis: Efficacy of a lenalidomide-rituximab-corticosteroid regimen.
Journal: JAAD case reports
Published: September 05, 2026
Erythema multiforme-like drug eruption in a patient with mycosis fungoides on durvalumab and lenalidomide.
Journal: JAAD case reports
Published: September 01, 2026
Hemophagocytic Lymphohistiocytosis as a Clinical Harbinger of Rapid Disease Progression in Multiple Myeloma During Daratumumab-Based Therapy.
Journal: Internal medicine (Tokyo, Japan)
Published: August 26, 2026
Influence of pH, Alcohol Structure, and Temperature on Lenalidomide Alcoholysis with Implications for Pharmaceutical Quality Control.
Journal: Chemical & pharmaceutical bulletin
Published: August 26, 2026
Fixed-duration lenalidomide maintenance: considering environmental value in multiple myeloma.
Journal: Haematologica
Published: August 11, 2026
Therapy-Related Acute Lymphoblastic Leukemia with Plasmablastic Morphology after Myeloma: a Pitfall.
Therapy-Related Acute Lymphoblastic Leukemia with Plasmablastic Morphology after Myeloma: a Pitfall.
Journal: Clinical laboratory
Published: August 08, 2026
Improvement of chylothorax after lymphangiography in AL amyloidosis
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 03, 2026
Disappearance of del (7q) with lenalidomide in myelofibrosis complicated with multiple myeloma
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 03, 2026
Selinexor combined bortezomib, lenalidomide, and dexamethasone for newly diagnosed multiple myeloma with high-risk factors: a single-arm, multi-center, prospective observational clinical study.
Journal: Annals of medicine
Published: August 03, 2026
Severe plaque psoriasis exacerbation during lenalidomide maintenance after autologous stem cell transplantation for multiple myeloma.
Journal: JAAD case reports
Published: August 01, 2026
Last Updated: 09/19/2026